PMID- 12392849 OWN - NLM STAT- MEDLINE DCOM- 20030411 LR - 20190906 IS - 0198-8859 (Print) IS - 0198-8859 (Linking) VI - 63 IP - 11 DP - 2002 Nov TI - Analysis of HLA-G expression in breast cancer tissues. PG - 969-76 AB - Among the different mechanisms by which cancer can elude the immune system, alterations in the expression of human leukocyte antigen (HLA) class I molecules on tumor cells may play a crucial role by impairing the HLA molecules interaction with T and natural killer (NK) cells specific receptors. More recently, aberrant expression of HLA-G has been described in different tumor tissues in addition to HLA class I downregulation. The HLA-G molecule is a nonclassical HLA class I antigen selectively expressed by trophoblast and thymic epithelial cells. Several studies reported that the HLA-G function might represent an additional mechanism of tumor immune escape, mainly inhibiting NK and cytotoxic T-cell activity. Here we report the analysis of HLA-G expression both at RNA level by reverse transcriptase-polymerase chain reaction and at protein level by Western blot and immunohistochemistry in 25 breast cancer patient tissues. The aim of this study was to elucidate the HLA-G gene expression pattern in breast tumor tissues and correlate it with HLA class I alterations. Our results demonstrated that HLA-G molecules expression was never found even in a group of patients revealing HLA class I total loss, and that HLA-G is not expressed in breast cancer tissue with a low-tumor grade (G1-G2) and minimal stromal contamination. FAU - Palmisano, Giulio Lelio AU - Palmisano GL AD - Laboratory of Molecular Morphogenesis, National Cancer Research Institute, Genova, Italy. palmisano@vega.cba.unige.it FAU - Pistillo, Maria Pia AU - Pistillo MP FAU - Fardin, Paolo AU - Fardin P FAU - Capanni, Paolo AU - Capanni P FAU - Nicolo, Guido AU - Nicolo G FAU - Salvi, Sandra AU - Salvi S FAU - Spina, Bruno AU - Spina B FAU - Pasciucco, Gennaro AU - Pasciucco G FAU - Ferrara, Giovanni Battista AU - Ferrara GB LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't PL - United States TA - Hum Immunol JT - Human immunology JID - 8010936 RN - 0 (HLA Antigens) RN - 0 (HLA-G Antigens) RN - 0 (Histocompatibility Antigens Class I) SB - IM MH - Blotting, Western MH - Breast Neoplasms/*immunology MH - Female MH - Genes, MHC Class I MH - HLA Antigens/*analysis/genetics/physiology MH - HLA-G Antigens MH - Histocompatibility Antigens Class I/*analysis/genetics/physiology MH - Humans MH - Immunohistochemistry MH - K562 Cells MH - Reverse Transcriptase Polymerase Chain Reaction MH - Tumor Cells, Cultured EDAT- 2002/10/24 04:00 MHDA- 2003/04/12 05:00 CRDT- 2002/10/24 04:00 PHST- 2002/10/24 04:00 [pubmed] PHST- 2003/04/12 05:00 [medline] PHST- 2002/10/24 04:00 [entrez] AID - S0198885902006420 [pii] AID - 10.1016/s0198-8859(02)00642-0 [doi] PST - ppublish SO - Hum Immunol. 2002 Nov;63(11):969-76. doi: 10.1016/s0198-8859(02)00642-0.